Microbiota

The Biocodex Group Strengthens Its Position in Microbiota, With the Signature of a Licensing Agreement With My Health, a Belgian Biotech Company Specializing in Microbiota Solutions

Retrieved on: 
수요일, 1월 17, 2024

Biocodex, a French pharmaceutical group with expertise in microbiota, women's health, orphan diseases, and My Health, a Belgian biotech company specializing in microbiota solutions, announce that they have signed a licensing agreement covering several countries in which the Biocodex Group operates, to market the DUOSPORE® dietary supplement.

Key Points: 
  • Biocodex, a French pharmaceutical group with expertise in microbiota, women's health, orphan diseases, and My Health, a Belgian biotech company specializing in microbiota solutions, announce that they have signed a licensing agreement covering several countries in which the Biocodex Group operates, to market the DUOSPORE® dietary supplement.
  • My Health was founded in 2017 by Raf Dybajlo.
  • In 2021, the company published a clinical study in The Lancet Gastroenterology & Hepatology on the efficacy of My Health’s proprietary strains, MY01 & MY02, in the treatment of functional dyspepsia (unexplained stomach complaints).
  • Raf Dybajlo, CEO of My Health, expresses enthusiasm for the strategic partnership with Biocodex: “I’m honored that My Health’s innovative research and commercial success have been recognized by Biocodex.

PNU Researchers Reveal Cutibacterium acnes as a Potential Cause of Lichen Striatus Hypopigmentation

Retrieved on: 
수요일, 1월 17, 2024

The gram-positive bacterium Cutibacterium acnes has previously been associated with various skin conditions, including acne vulgaris and post-inflammatory hypopigmentation.

Key Points: 
  • The gram-positive bacterium Cutibacterium acnes has previously been associated with various skin conditions, including acne vulgaris and post-inflammatory hypopigmentation.
  • There could, therefore, be a potential association between C. acnes and the observed skin microbiota of patients with LS with and without hypopigmentation.
  • Comparing patients with LS with and without hypopigmentation, the researchers discovered a quadrupled presence (23.26% versus 5.29% of the entire microbiota) of Cutibacterium acnes in the former.
  • Title of original paper: Association between the skin microbiome and lichen striatus hypopigmentation: Cutibacterium acnes as a potential cause

Space travel taxes astronauts' brains. But microbes on the menu could help in unexpected ways

Retrieved on: 
수요일, 1월 17, 2024

Providing astronauts with the right diet is also paramount in supporting their mental and cognitive health, in a way unlike previous missions.

Key Points: 
  • Providing astronauts with the right diet is also paramount in supporting their mental and cognitive health, in a way unlike previous missions.
  • That includes acknowledging the role of microbes in mental health and wellbeing, and providing astronauts with the right foods and conditions for a variety of these beneficial microbes to grow.
  • Here’s why a healthy balance of microbes is important under such challenging conditions, and how we could put microbes on the menu.

Why are missions to Mars so challenging?

  • Deep space missions will expose humans to immense physical and psychological challenges.
  • These include prolonged isolation from loved ones, extreme space and resource constraints, and the difficulties of microgravity.

Why is diet important for mental health?

  • We already know the quality of people’s diet not only influences their physical health, but also their mental and brain health.
  • Diet quality is consistently and independently linked to the risk of depression or anxiety.


Diet can have such consequences by altering:
Diet can also influence the many ways microbes in the gut affect the brain, a link known as the microbiota gut-brain axis.

Read more:
Essays on health: microbes aren't the enemy, they're a big part of who we are

Not all foods make the grade

  • Space foods need to appeal to a diverse crew and stay nutritious for an extremely long time (likely a three- to five-year mission).
  • They also need to be lightweight and compact enough to fit on the spacecraft.

Why are microbes so important?

  • We have co-evolved with, and are hosts to, trillions of different microbes that live on our skin and in all our niches and cavities.
  • Gut microbes influence our mental health and behaviour, and these, in turn, influence our gut microbes.
  • So ensuring all astronauts have the healthiest and most diverse of microbes for the whole of the mission is vital.

How could we encourage healthy microbes?

  • We also need to think about how we grow the food if we are to support healthy microbiomes.
  • Indeed, microbes play an essential role in the nutrient and phytochemical content of plants, and the microbes in soil, plants and humans are interconnected.
  • Some types have a meat-like flavour and texture, and can provide all the amino acids humans need as well as useful byproducts from the microbes themselves.
  • Fermentation itself creates thousands of different bioactive molecules, including some vitamins, that have diverse beneficial effects on health, including possible benefits to mental health.
  • Probiotics are live microbes that have demonstrated health benefits and prebiotics are food for these healthy microbes.

Benefits on Earth too


We’re only at the start of learning how to optimise microbes to keep space crews healthy, which is crucial for long space flights and for possible settlement on other planets. However, this research could have many other applications. We can use what we learn to help create self-sustaining and sustainable food systems on Earth to improve the environment and human health.

  • She is on the Scientific Advisory Board of the Dauten Family Centre for Bipolar Treatment Innovation and Zoe Limited.
  • Dorit Donoviel is Executive Director, NASA-Funded Translational (moving products from lab-bench to practice) Research Institute for Space Health at Baylor College of Medicine.

New Global Observatory Survey Shows US Healthcare Providers Can Do More to Educate Patients on the Microbiota

Retrieved on: 
화요일, 1월 16, 2024

BEDMINSTER, N.J., Jan. 16, 2024 /PRNewswire-PRWeb/ -- Made up of billions of microorganisms, the human microbiota plays a vital role in health and overall wellbeing, including essential body functions like digestion, urinary tract health, weight, vaginal health and more. However, a new study by the Biocodex Microbiota Institute and Ipsos, which included 1,000 U.S. adults as part of a global survey, found that less than half of Americans understand what the microbiome is. This corresponds closely with the fact that more than half of U.S. respondents also said they have not received information about the microbiome from their healthcare provider (includes physicians, physician assistants and nurse practitioners).

Key Points: 
  • We see this as an opportunity for medical professionals to raise awareness about the opportunity to support a healthy microbiota.
  • In the US, patient education is key to explaining both the role of the microbiota and the behaviors needed to best preserve them.
  • Only 1 in 4 Americans has ever had the role of their microbiota explained to them by their healthcare professional.
  • Family physicians are the main healthcare providers who provide information about microbiome with gastroenterologists coming in next, but to a lesser extent.

NutriLeads Completes 4.5 Million Euro Series C Financing to Accelerate Commercialization of BeniCaros as a Global Precision Prebiotic Brand

Retrieved on: 
월요일, 12월 18, 2023

WAGENINGEN, The Netherlands, Dec. 18, 2023 (GLOBE NEWSWIRE) -- NutriLeads BV today announced that it has raised 4.5 million euros in a Series C investment round to accelerate the commercialization of BeniCaros®, the company’s award-winning precision prebiotic fiber for enhancing immune and gut health.

Key Points: 
  • WAGENINGEN, The Netherlands, Dec. 18, 2023 (GLOBE NEWSWIRE) -- NutriLeads BV today announced that it has raised 4.5 million euros in a Series C investment round to accelerate the commercialization of BeniCaros®, the company’s award-winning precision prebiotic fiber for enhancing immune and gut health.
  • The financing was led by existing investor dsm-firmenich Venturing with the support from the other current investors.
  • The funding will support expansion in new consumer markets and geographies, and the creation of a global brand for this innovative food, beverage and dietary supplement ingredient.
  • “BeniCaros offers health benefits for consumers of all ages,” said Joana Carneiro, Ph.D., NutriLeads Chief Executive Officer.

GENFIT Highlights ACLF Development Strategy at “ACLF Day” during AASLD The Liver Meeting® 2023

Retrieved on: 
목요일, 11월 16, 2023

GENFIT is now mainly focused on the development of therapies for ACLF which is an area of very high unmet medical need.

Key Points: 
  • GENFIT is now mainly focused on the development of therapies for ACLF which is an area of very high unmet medical need.
  • ACLF is a potentially deadly, but reversible, condition in patients with chronic liver diseases, which is associated with multi-organ failure and high short-term mortality.
  • Pascal Prigent, CEO of GENFIT, commented: “During AASLD we were excited to further discuss our development strategy around our new pipeline focused on ACLF, where we believe multiple programs have the potential to transform the treatment paradigm for these patients.
  • As part of the “ACLF Day” event during AASLD, the critical need for treatment has been highlighted by leading experts in ACLF.

CU Medicine study published in The Lancet Infectious Diseases concludes that a novel oral microencapsulated live bacteria consortia (SIM01) alleviates long COVID symptoms

Retrieved on: 
금요일, 12월 8, 2023

The study has profound implications for the role of gut microbiota modulation in improving symptoms in subjects with long COVID.

Key Points: 
  • The study has profound implications for the role of gut microbiota modulation in improving symptoms in subjects with long COVID.
  • The landmark findings have recently been published in The Lancet Infectious Disease, a publication from The Lancet Group.
  • Long COVID refers to long-term symptoms involving multiple systems and organs that persist in recovered COVID-19 patients.
  • The research team has previously shown that patients with long COVID lacked a series of beneficial gut bacteria, which may contribute to multiple symptoms.

CU Medicine study published in The Lancet Infectious Diseases concludes that a novel oral microencapsulated live bacteria consortia (SIM01) alleviates long COVID symptoms

Retrieved on: 
금요일, 12월 8, 2023

The study has profound implications for the role of gut microbiota modulation in improving symptoms in subjects with long COVID.

Key Points: 
  • The study has profound implications for the role of gut microbiota modulation in improving symptoms in subjects with long COVID.
  • The landmark findings have recently been published in The Lancet Infectious Disease, a publication from The Lancet Group.
  • Long COVID refers to long-term symptoms involving multiple systems and organs that persist in recovered COVID-19 patients.
  • The research team has previously shown that patients with long COVID lacked a series of beneficial gut bacteria, which may contribute to multiple symptoms.

Alliance Promotion Microbiote To Welcome Ferring Pharmaceuticals, Pelican Health and Polepharma as New Members

Retrieved on: 
목요일, 11월 9, 2023

With more than 20 current members, APM today welcomes Ferring Pharmaceuticals, Pelican Health and Polepharma, three major contributors to the development, the production, and the commercialization of microbiome-based therapeutic and diagnostic innovations for patients.

Key Points: 
  • With more than 20 current members, APM today welcomes Ferring Pharmaceuticals, Pelican Health and Polepharma, three major contributors to the development, the production, and the commercialization of microbiome-based therapeutic and diagnostic innovations for patients.
  • Headquartered in Saint-Prex, Switzerland, Ferring is a leader in reproductive medicine and maternal health, and in specialty areas within gastroenterology and urology.
  • Ferring has been developing treatments for mothers and babies for over 50 years and has a portfolio covering treatments from conception to birth.
  • www.polepharma.com
    Hervé Affagard, President of Alliance Promotion Microbiote states "We are thrilled to extend a warm welcome to Ferring Pharmaceuticals, Pelican Health, and Polepharma as they join our microbiome-focused association.

Human Biome Announces Prediction of first-in class, Biosynthetic Microbiome Against Silent Pandemic of Antibiotic-Resistant Bacteria and Doses First Patients in Contextual FMT Study to validate it

Retrieved on: 
화요일, 10월 31, 2023

WARSAW, Poland, Oct. 31, 2023 /PRNewswire/ -- This is a major milestone for Human Biome, the field of microbiome medicine and whole epidemiology.

Key Points: 
  • WARSAW, Poland, Oct. 31, 2023 /PRNewswire/ -- This is a major milestone for Human Biome, the field of microbiome medicine and whole epidemiology.
  • Antibiotic resistance is a growing threat to public health, and new treatments are urgently needed.
  • The New-Generation Biotherapeutic (NGB) drug candidate has the potential to provide a new paradigm in preventing antibiotic-resistant bacteria (ARB) infections.
  • Now, we have predicted fully synthetic microbiome drug composition and our AI-based analysis confirms its efficacy – commented CEO and R&D Director of Human Biome Jaroslaw Bilinski MD, PhD.